Thymic carcinoma
Primary thymic carcinoma refers to a thymic epithelial tumor with malignant cell structural characteristics. In concept and practice, it is easily confused with malignant thymoma and thymic metastatic carcinoma. The most common tissue types are squamous cell carcinoma and undifferentiated carcinoma, and most patients have different symptoms. The treatment is mainly surgical resection and radiotherapy, but the efficacy and prognosis are poor.
-
Site of disease:
Mediastinum -
Infectious :
Not contagious -
Frequent population:
People aged 40-60 -
Related symptoms:
Weight loss chest pain night sweats breathing difficulties chest pain -
Concurrent disease:
Related Drugs
Cyclosporine Injection
Indication: For treatment: 1. Organ transplantation: 1) Prevention of rejection of kidney, liver, heart, combined heart-lung, lung and pancreas transplants. 2) Treatment of transplant rejection in patients before receiving other immunosuppressants. Due to the risk of allergy to this product (see Precautions), this product can only be intravenously infused when oral administration is not possible (such as just after surgery) or gastrointestinal absorption is impaired. Such patients should switch to oral cyclosporine treatment as soon as possible; 2. Bone marrow transplantation: 1) Prevention of rejection after transplantation. 2) Initial prevention and treatment of graft-versus-host disease (GVHD).
Manufacturer:
Cisen Pharmaceutical Co., Ltd.
Related Ingredients